The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm

Adina Brett-Morris, Bradley M. Wright, Yuji Seo, Vinay Pasupuleti, Junran Zhang, Jun Lu, Raffaella Spina, Eli E. Bar, Maneesh Gujrati, Rebecca Schur, Zheng Rong Lu, Scott Welford

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM) is the most common and severe form of brain cancer. The median survival time of patients is approximately 12 months due to poor responses to surgery and chemoradiation. To understand the mechanisms involved in radioresistance, we conducted a genetic screen using an shRNA library to identify genes in which inhibition would sensitize cells to radiation. The results were cross-referenced with the Oncomine and Rembrandt databases to focus on genes that are highly expressed in GBM tumors and associated with poor patient outcomes. Spermidine/spermine-N1-acetyltransferase 1 (SAT1), an enzyme involved in polyamine catabolism, was identified as a gene that promotes resistance to ionizing radiation (IR), is overexpressed in brain tumors, and correlates with poor outcomes. Knockdown of SAT1 using shRNA and siRNA approaches in multiple cell and neurosphere lines resulted in sensitization of GBM cells to radiation in colony formation assays and tumors, and decreased tumorigenesis in vivo. Radiosensitization occurred specifically in G2-Mand S phases, suggesting a role for SAT1 in homologous recombination (HR) that was confirmed in a DR-GFP reporter system. Mechanistically, we found that SAT1 promotes acetylation of histone H3, suggesting a new role of SAT1 in chromatin remodeling and regulation of gene expression. In particular, SAT1 depletion led to a dramatic reduction in BRCA1 expression, explaining decreased HR capacity. Our findings suggest that the biologic signi ficance of elevated SAT1 expression inGBM lies in its contribution to cell radioresistance and that SAT1 may potentially be a therapeutic target to sensitizeGBMto cancer therapies.

Original languageEnglish (US)
Pages (from-to)6925-6934
Number of pages10
JournalCancer Research
Volume74
Issue number23
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Spermine
Polyamines
Acetyltransferases
Carcinogenesis
Radiation
Enzymes
Glioblastoma
Small Interfering RNA
Homologous Recombination
Brain Neoplasms
Genes
Neoplasms
Chromatin Assembly and Disassembly
Gene Expression Regulation
Acetylation
Ionizing Radiation
S Phase
Histones
Databases
Cell Line

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm. / Brett-Morris, Adina; Wright, Bradley M.; Seo, Yuji; Pasupuleti, Vinay; Zhang, Junran; Lu, Jun; Spina, Raffaella; Bar, Eli E.; Gujrati, Maneesh; Schur, Rebecca; Lu, Zheng Rong; Welford, Scott.

In: Cancer Research, Vol. 74, No. 23, 01.12.2014, p. 6925-6934.

Research output: Contribution to journalArticle

Brett-Morris, A, Wright, BM, Seo, Y, Pasupuleti, V, Zhang, J, Lu, J, Spina, R, Bar, EE, Gujrati, M, Schur, R, Lu, ZR & Welford, S 2014, 'The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm', Cancer Research, vol. 74, no. 23, pp. 6925-6934. https://doi.org/10.1158/0008-5472.CAN-14-1249
Brett-Morris A, Wright BM, Seo Y, Pasupuleti V, Zhang J, Lu J et al. The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm. Cancer Research. 2014 Dec 1;74(23):6925-6934. https://doi.org/10.1158/0008-5472.CAN-14-1249
Brett-Morris, Adina ; Wright, Bradley M. ; Seo, Yuji ; Pasupuleti, Vinay ; Zhang, Junran ; Lu, Jun ; Spina, Raffaella ; Bar, Eli E. ; Gujrati, Maneesh ; Schur, Rebecca ; Lu, Zheng Rong ; Welford, Scott. / The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm. In: Cancer Research. 2014 ; Vol. 74, No. 23. pp. 6925-6934.
@article{cb887eaa01a1498596e159ff4b206c37,
title = "The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm",
abstract = "Glioblastoma multiforme (GBM) is the most common and severe form of brain cancer. The median survival time of patients is approximately 12 months due to poor responses to surgery and chemoradiation. To understand the mechanisms involved in radioresistance, we conducted a genetic screen using an shRNA library to identify genes in which inhibition would sensitize cells to radiation. The results were cross-referenced with the Oncomine and Rembrandt databases to focus on genes that are highly expressed in GBM tumors and associated with poor patient outcomes. Spermidine/spermine-N1-acetyltransferase 1 (SAT1), an enzyme involved in polyamine catabolism, was identified as a gene that promotes resistance to ionizing radiation (IR), is overexpressed in brain tumors, and correlates with poor outcomes. Knockdown of SAT1 using shRNA and siRNA approaches in multiple cell and neurosphere lines resulted in sensitization of GBM cells to radiation in colony formation assays and tumors, and decreased tumorigenesis in vivo. Radiosensitization occurred specifically in G2-Mand S phases, suggesting a role for SAT1 in homologous recombination (HR) that was confirmed in a DR-GFP reporter system. Mechanistically, we found that SAT1 promotes acetylation of histone H3, suggesting a new role of SAT1 in chromatin remodeling and regulation of gene expression. In particular, SAT1 depletion led to a dramatic reduction in BRCA1 expression, explaining decreased HR capacity. Our findings suggest that the biologic signi ficance of elevated SAT1 expression inGBM lies in its contribution to cell radioresistance and that SAT1 may potentially be a therapeutic target to sensitizeGBMto cancer therapies.",
author = "Adina Brett-Morris and Wright, {Bradley M.} and Yuji Seo and Vinay Pasupuleti and Junran Zhang and Jun Lu and Raffaella Spina and Bar, {Eli E.} and Maneesh Gujrati and Rebecca Schur and Lu, {Zheng Rong} and Scott Welford",
year = "2014",
month = "12",
day = "1",
doi = "10.1158/0008-5472.CAN-14-1249",
language = "English (US)",
volume = "74",
pages = "6925--6934",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - The polyamine catabolic enzyme sat1 modulates tumorigenesis and radiation response in gbm

AU - Brett-Morris, Adina

AU - Wright, Bradley M.

AU - Seo, Yuji

AU - Pasupuleti, Vinay

AU - Zhang, Junran

AU - Lu, Jun

AU - Spina, Raffaella

AU - Bar, Eli E.

AU - Gujrati, Maneesh

AU - Schur, Rebecca

AU - Lu, Zheng Rong

AU - Welford, Scott

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Glioblastoma multiforme (GBM) is the most common and severe form of brain cancer. The median survival time of patients is approximately 12 months due to poor responses to surgery and chemoradiation. To understand the mechanisms involved in radioresistance, we conducted a genetic screen using an shRNA library to identify genes in which inhibition would sensitize cells to radiation. The results were cross-referenced with the Oncomine and Rembrandt databases to focus on genes that are highly expressed in GBM tumors and associated with poor patient outcomes. Spermidine/spermine-N1-acetyltransferase 1 (SAT1), an enzyme involved in polyamine catabolism, was identified as a gene that promotes resistance to ionizing radiation (IR), is overexpressed in brain tumors, and correlates with poor outcomes. Knockdown of SAT1 using shRNA and siRNA approaches in multiple cell and neurosphere lines resulted in sensitization of GBM cells to radiation in colony formation assays and tumors, and decreased tumorigenesis in vivo. Radiosensitization occurred specifically in G2-Mand S phases, suggesting a role for SAT1 in homologous recombination (HR) that was confirmed in a DR-GFP reporter system. Mechanistically, we found that SAT1 promotes acetylation of histone H3, suggesting a new role of SAT1 in chromatin remodeling and regulation of gene expression. In particular, SAT1 depletion led to a dramatic reduction in BRCA1 expression, explaining decreased HR capacity. Our findings suggest that the biologic signi ficance of elevated SAT1 expression inGBM lies in its contribution to cell radioresistance and that SAT1 may potentially be a therapeutic target to sensitizeGBMto cancer therapies.

AB - Glioblastoma multiforme (GBM) is the most common and severe form of brain cancer. The median survival time of patients is approximately 12 months due to poor responses to surgery and chemoradiation. To understand the mechanisms involved in radioresistance, we conducted a genetic screen using an shRNA library to identify genes in which inhibition would sensitize cells to radiation. The results were cross-referenced with the Oncomine and Rembrandt databases to focus on genes that are highly expressed in GBM tumors and associated with poor patient outcomes. Spermidine/spermine-N1-acetyltransferase 1 (SAT1), an enzyme involved in polyamine catabolism, was identified as a gene that promotes resistance to ionizing radiation (IR), is overexpressed in brain tumors, and correlates with poor outcomes. Knockdown of SAT1 using shRNA and siRNA approaches in multiple cell and neurosphere lines resulted in sensitization of GBM cells to radiation in colony formation assays and tumors, and decreased tumorigenesis in vivo. Radiosensitization occurred specifically in G2-Mand S phases, suggesting a role for SAT1 in homologous recombination (HR) that was confirmed in a DR-GFP reporter system. Mechanistically, we found that SAT1 promotes acetylation of histone H3, suggesting a new role of SAT1 in chromatin remodeling and regulation of gene expression. In particular, SAT1 depletion led to a dramatic reduction in BRCA1 expression, explaining decreased HR capacity. Our findings suggest that the biologic signi ficance of elevated SAT1 expression inGBM lies in its contribution to cell radioresistance and that SAT1 may potentially be a therapeutic target to sensitizeGBMto cancer therapies.

UR - http://www.scopus.com/inward/record.url?scp=84917691027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84917691027&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-14-1249

DO - 10.1158/0008-5472.CAN-14-1249

M3 - Article

VL - 74

SP - 6925

EP - 6934

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 23

ER -